MetaCap

Novo Nordisk A/S Statistics

NYSE: NVOHealth CareBiotechnology: Pharmaceutical PreparationsUSD

37.82-1.05 (-2.70%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Novo Nordisk A/S by the numbers

Novo Nordisk A/S has a market capitalization of $166.69 billion based on 3.33B shares outstanding. Its trailing P/E ratio is 9.6, below the 8-company peer median of 28.1, and its forward P/E is 10.8. The stock trades 4.5% below its 50-day average and 11.8% below its 200-day average.

Average daily trading volume is 12.59M shares, or about $476.3 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

NVO valuation vs. peer median

NVO compared with the median of 8 peer companies
MetricNVOPeer medianDifference
Market cap$166.69B$115.95B+44%
P/E (TTM)9.628.1-66%
Forward P/E10.811.2-4%
Dividend yield30.94%4.29%+622%
Avg. volume12.59M3.72M+239%

Peer median across 8 companies: PFE, ABT, VRTX, BMY, SNY, GSK, REGN, TAK.

Valuation

Price and trading

Previous close
38.87
Open
38.44
Day range
37.75 – 39.11
52-week range
35.12 – 64.16
52-week change
-20.60%
Beta
—
Volume
13.04M

Dividends and events

Annual dividend
$11.70

Additional statistics

Market Cap
166.69B
Pe
9.55
Forward Pe
10.77
Eps
3.96
Dividend Yield
4.75%
Dividend Rate
11.70
Week52 High
64.16
Week52 Low
35.12
Avg Volume
12.59M
Shares Outstanding
3.33B
Ma50
39.59
Ma200
42.88
Earnings Date
Feb 3, 2027
Pct From52w High
-41.05%
Pct From52w Low
7.69%

Related